Company profile: TMC Pharma Services
1.1 - Company Overview
Company description
- Provider of pharmaceutical and biotech drug development support, offering clinical and nonclinical services, medical support and pharmacovigilance. Capabilities include regulatory strategy and submissions (pre- and post-approval), GxP quality assurance audits and consultancy, medical writing, orphan drug designation applications, paediatric investigation plans, and clinical trial applications with pre-clinical data review/validation.
Products and services
- Regulatory Support & Activities: Delivers strategic advice and guidance for global regulatory affairs and submissions, covering pre‑approval to post‑approval phases
- Clinical Trial Applications: Architects, prepares, and submits clinical trial applications, including review and validation of pre‑clinical data via a preclinical‑validated process
- Quality Assurance: Conducts audits and consultancy across multiple GxP areas, delivering GxP‑compliant quality assurance services for regulated development activities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TMC Pharma Services
OctoPlus
HQ: The Netherlands
Website
- Description: Provider of specialty pharmaceutical expertise in the development of injectables. Based in a leading European bioscience park, the company is globally renowned and employs around 120 people representing over 20 nationalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OctoPlus company profile →
Ajinomoto Bio-Pharma Services
HQ: United States
Website
- Description: Provider of manufacturing and process development services, covering small molecule API and intermediate production from pre-clinical to commercialization, large molecule biologics with microbial cell banking and expression systems, high potency and ADC manufacturing with GLP bioconjugation, oligonucleotide and peptide synthesis (solid phase, Ajiphase), and drug product formulation, fill finish, packaging, and storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ajinomoto Bio-Pharma Services company profile →
ProBioGen
HQ: Germany
Website
- Description: Provider of contract development and manufacturing and technology services for biopharmaceuticals, specializing in cell line engineering, scalable upstream and downstream process development, GMP manufacturing, and virus production. Offers development and manufacturing of therapeutic proteins and antibodies, custom stable production cell lines, and support for biosimilars and biobetters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProBioGen company profile →
Veristat
HQ: United Kingdom
Website
- Description: Provider of full-service, science-focused CRO support for pharmaceutical, biotechnology, and medical device companies, with 20+ years of experience in clinical trials and regulatory submissions. Services include clinical operations, project management, monitoring and site management, patient recruitment and retention (including an in-house call center), and medical safety across global trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veristat company profile →
Persano
HQ: Denmark
Website
- Description: Provider of manufactured cosmetics, dietary supplements, medical equipment, drugs, and health care products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Persano company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TMC Pharma Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TMC Pharma Services
2.2 - Growth funds investing in similar companies to TMC Pharma Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TMC Pharma Services
4.2 - Public trading comparable groups for TMC Pharma Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →